ANNE EDMONDS: Open Payments
NPI 1003352543 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,185 in 107 payments from 15 companies in 2025. Trend: 2023 $3,630 · 2024 $3,945 · 2025 $2,185
Food & beverage: $2,185
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $469 |
| UCB, Inc. | 16 | $325 |
| Janssen Biotech, Inc. | 13 | $264 |
| Regeneron Healthcare Solutions, Inc. | 6 | $233 |
| Novartis Pharmaceuticals Corporation | 11 | $217 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $200 |
| Lilly USA, LLC | 6 | $112 |
| E.R. Squibb & Sons, L.L.C. | 4 | $84 |
| Arcutis Biotherapeutics, Inc. | 5 | $77 |
| PFIZER INC. | 3 | $50 |
Products named: Bimzelx, DUPIXENT, TREMFYA, RINVOQ, SKYRIZI, ILUMYA, COSENTYX, TALTZ.
Industry payments across OK — which companies pay providers there.
